These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6346093)

  • 1. [Concentration-time relations in the effect of nystatin on Candida albicans multiplication].
    Rumler W; Heins S
    Mykosen; 1983 Apr; 26(4):216-20. PubMed ID: 6346093
    [No Abstract]   [Full Text] [Related]  

  • 2. [Concentration-contact time relationship in the effect of antimycotic drug combinations (clotrimazole, nystatin, 5-fluorocytosine) and the effect of increasing and decreasing antimycotic drug concentrations on Candida albicans].
    Rumler W; Heins S
    Mykosen; 1985 May; 28(5):251-7. PubMed ID: 3892290
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipid composition and polyene antibiotic sensitivity in isolates of Candida albicans.
    Singh M; Jayakumar A; Prasad R
    Microbios; 1979; 24(95):7-17. PubMed ID: 393957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Freeze fracture electron microscopical investigation of Candida albicans cells sensitive and resistant to nystatin.
    Pesti M; Novák EK; Ferenczy L; Svoboda A
    Sabouraudia; 1981 Mar; 19(1):17-26. PubMed ID: 7013113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ultrastructural changes in Candida albicans exposed to polyene antibiotics].
    Delektorskiĭ VV; Sheklakov ND; Golodova OA
    Vestn Dermatol Venerol; 1980 Nov; (11):14-6. PubMed ID: 7003976
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro development of resistance to nystatin by Candida albicans and Torulopsis glabrata.
    Nobre GN; Pereira A; Coias R; Cordeiro J
    J Gen Microbiol; 1980 May; 118(1):263-5. PubMed ID: 6999124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Availability of nystatin from various dermatologic agents against Candida albicans].
    Elkhouly AE
    Mykosen; 1976 Jul; 19(7):227-37. PubMed ID: 790174
    [No Abstract]   [Full Text] [Related]  

  • 8. [Activity of nystatin in an artificial gastric environment].
    Boudru I
    J Pharm Belg; 1972; 26(3):305-15. PubMed ID: 4558723
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of nystatin on the morphology of Candida albicans.
    Pugh D; Cawson RA
    Sabouraudia; 1978 Dec; 16(4):307-11. PubMed ID: 377525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies in vitro on the susceptibility of yeast-like fungi of Candida genus to nystatin].
    Pekowski M; Gwieździński Z; Kozlowski J
    Przegl Dermatol; 1972; 59(3):365-71. PubMed ID: 4559291
    [No Abstract]   [Full Text] [Related]  

  • 11. Some characteristics of nystatin-resistant sterol mutants of Candida albicans.
    Pesti M; Paku S; Novák EK
    Acta Microbiol Acad Sci Hung; 1982; 29(1):55-66. PubMed ID: 7046355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candida resistant to nystatin becomes sensitive upon culture with ergosterol.
    Mas J; Piña E
    Arch Invest Med (Mex); 1985; 16(2):145-55. PubMed ID: 3907567
    [No Abstract]   [Full Text] [Related]  

  • 13. Calcium, sequestering agents and nystatin--interactions on cell wall morphology and fungistasis of Candida albicans.
    Pugh D; Cawson RA
    Sabouraudia; 1980 Jun; 18(2):157-9. PubMed ID: 6775378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in the cell wall of Candida albicans cultivated in the presence of sublethal doses of nystatin].
    Bonaly R; Dari L; Kubiak C; Lejeune C; Lematre J; Poulain D
    Ann Inst Pasteur Microbiol (1985); 1985; 136B(2):181-93. PubMed ID: 3909932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of miconazole on ergosterol-less mutant of Candida albicans.
    Pesti M; Becher D; Bartsch G
    Acta Microbiol Hung; 1983; 30(1):25-9. PubMed ID: 6362313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ultrastructural changes in Candida albicans caused by polyene antibiotics (author's transl)].
    Scheklakow ND; Delektorski WW; Golodova OA
    Mykosen; 1981 Mar; 24(3):140-52. PubMed ID: 7024797
    [No Abstract]   [Full Text] [Related]  

  • 17. An ex-vivo oral mucosa infection model for the evaluation of the topical activity of antifungal agents.
    Ohnemus U; Willers C; Bubenheim M; Horstkotte MA; Houdek P; Fischer F; Schmage P; Moll I; Brandner JM
    Mycoses; 2008 Jan; 51(1):21-9. PubMed ID: 18076591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The antimycotic effect of a nystatin-containing suspension under influence of gastric juice of different pH-values and with varying duration of action (author's transl)].
    Hussain H; Casten C
    Mykosen; 1981 Feb; 24(2):97-101. PubMed ID: 7015127
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of antimycetics in vitro on the growth of Candida albicans and its developmental forms.
    Serfözö J; Halmy K
    Mykosen; 1980 Feb; 23(2):89-95. PubMed ID: 6991939
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus.
    Willis AM; Coulter WA; Fulton CR; Hayes JR; Bell PM; Lamey PJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):317-21. PubMed ID: 11250629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.